🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchClinicalTrials.gov GLP-1 trial tracker — updated weekly Page 7

ClinicalTrials.gov GLP-1 trial tracker — updated weekly

TrialTracker_MD Fri, Dec 1, 2023 at 4:00 PM 75 replies 57,779 viewsPage 7 of 15
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Dec 2, 2023 at 1:55 AM#31

Moderator note: This thread has been getting great engagement. Please remember to cite sources when making clinical claims.

No issues to report — carry on. 👍

12 10PharmHunterJen, TomTeleRx, DoseLogDan and 9 others
Reply Quote Save Share Report
quinn_sf
Member
489
2,123
Jun 2024
San Francisco, CA
Dec 2, 2023 at 2:12 AM#32

Subscribing to this thread. ClinicalTrials.gov GLP-1 is exactly what I've been researching. 🙏

45 17Dr.PathRoch, mona_PHX, andrew_nyc and 42 others
Reply Quote Save Share Report
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Dec 2, 2023 at 2:29 AM#33

OP here — wow, did not expect this much response! Thank you all for the thoughtful replies on ClinicalTrials.gov GLP-1.

To answer TrialTracker_MD: my doctor and I discussed the options and went with brand.

Quick update: I have noticed more improvement since posting this. Thanks again for the evidence-based discussion — this is exactly why I posted in a science-based community. 🙏

Last edited: Dec 2, 2023 at 7:29 AM
48 14maya_sedona, stefan_berlin, Dr.EM_Chicago and 45 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
amsterdam_pete
Senior Member
1,567
6,789
Feb 2024
Netherlands
Dec 2, 2023 at 2:46 AM#34

Yep. My endo said the same thing about ClinicalTrials.gov.

2 9KetoKyle, CanadaChris
Reply Quote Save Share Report
MounjBrad
Member
278
890
Oct 2024
Kentucky
Dec 2, 2023 at 3:03 AM#35

+1 to Dr.RheumBOS. Especially the point about "gov GLP-1 but rachel_ABQ reminded me — d..." — I have seen the same in my own experience with ClinicalTrials.gov GLP-1.

17 21marco_milano, pam_columbus, nick_SD_fit and 14 others
Reply Quote Save Share Report
15678915

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register